Recombinant Neisseria meningitides β1,3-N-acetylgalactosaminyltransferase (LgtD), E. coli

Cat. No.: XET010Q

Recombinant Neisseria meningitides β1,3-N-acetylgalactosaminyltransferase (LgtD), E. coli

Synonym: LgtD; Beta-1,3-GalNAc-T1; Beta-1,3-galactosyltransferase 3

  • Enzyme Commission Number: 2.4.1.79
Product Size
1 unit; 5 units; 10 units
Price
Datasheet
MSDS
Properties
Description
It is an recombinant Neisseria meningitides β1,3-N-acetylgalactosaminyltransferase (LgtD) produced in E. coli. This product can be used to study the mode of action of the enzyme and its potential inhibitors, and can also be used as a glycoengineering tool to modify glycoproteins in vitro.
Purity
>95%, determined by SDS-PAGE.
Unit Definition
One unit will catalyze the formation of 1 μmol GalNAcβ(1-3)Gal from UDP-GalNAc and Gal per min at 37°C.
Source
Neisseria meningitides
Form
Lyophilized powder
Applications
Study the mode of action of the enzyme and its potential inhibitors and as a glycoengineering tool to modify glycoproteins in vitro.
Storage
Store at -20°C.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.